This archive covers milestones and breakthroughs from the scientific and academic world — researchers, universities, and institutions whose work advances human knowledge. Stories here highlight discoveries, studies, and scholarly efforts that point toward a better future.
The Alzheimer’s Association called the robust study from American biotech company Biogen “the most encouraging results in clinical trials treating the underlying causes of Alzheimer’s to date.”
Clean energy storage just took a major leap forward, and it happened without a single fossil fuel involved. China’s new compressed air facility in Zhangjiakou runs entirely on thermodynamic processes, storing up to 400 MWh and operating at 70.4% efficiency — well above the 40–52% typical of existing systems. That’s enough to supply more than 132 GWh to the local grid annually, while avoiding roughly 109,000 tons of CO₂ each year. Proving that utility-scale, non-lithium storage can work commercially gives the global clean energy transition a powerful new tool to build on.
CERVAVAC, India’s first homegrown cervical cancer vaccine, is priced at just $2.50 to $5.00 per dose — a fraction of what HPV vaccines have cost in wealthy countries for nearly two decades. Developed by the Serum Institute of India, it protects against the HPV strains responsible for the majority of cervical cancers worldwide, and the company aims to produce around 200 million doses in its first two years. Cervical cancer is almost entirely preventable, yet it still kills hundreds of thousands of women each year, mostly in lower-income countries where vaccines have been priced out of reach. An affordable, locally made option doesn’t just change the math for India — it points toward a future where health tools belong to the people who need them most.
Lupus remission in all five patients — that’s the striking result from a small German trial using CAR T-cell therapy, a treatment originally developed for blood cancers. Doctors collected each patient’s own T-cells, reprogrammed them to clear out the malfunctioning B cells driving the disease, and reinfused them. Months later, the patients’ immune systems had essentially rebooted: new B cells grew back, but they no longer attacked the body. None have needed lupus medication since. The lead researcher believes the same approach could help people with rheumatoid arthritis, multiple sclerosis, and other autoimmune conditions — opening a hopeful new chapter for millions worldwide who have long managed their illness without ever truly being free of it.
Even low-level exposure to these chemicals over a sustained amount of time can lead to serious health effects, including thyroid disease, reduced immune response, and several cancers.
The double-blind longitudinal study followed nearly 1,000 patients with Lynch Syndrome, an inherited genetic condition that increases the individual risk of several cancers, for almost 20 years.
The Bochum researchers hope that an early diagnosis based on the amyloid-beta misfolding could help to apply Alzheimer’s drugs at such an early stage that they have a significantly better effect.
The amount of CO2 emitted during kerosene combustion in a jet engine equals that consumed during its production in the solar plant.
The introduction of such a program, which is offered to any students registered to any of the state’s 22 federally recognized tribes, is the first of its kind in an Arizona public university.
Experts are predicting that this new photoimmunotherapy will be the world’s fifth major cancer treatment following surgery, chemotherapy, radiotherapy, and immunotherapy.
